- Home
- VRAX vs JVA Comparison
VRAX vs JVA Comparison
Compare VRAX & JVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAX
- JVA
- Stock Information
- Founded
- VRAX 2013
- JVA 1971
- Country
- VRAX United Kingdom
- JVA United States
- Employees
- VRAX N/A
- JVA N/A
- Industry
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- JVA Packaged Foods
- Sector
- VRAX Health Care
- JVA Consumer Staples
- Exchange
- VRAX Nasdaq
- JVA Nasdaq
- Market Cap
- VRAX 17.2M
- JVA 14.7M
- IPO Year
- VRAX 2022
- JVA 2005
- Fundamental
- Price
- VRAX $2.80
- JVA $2.89
- Analyst Decision
- VRAX
- JVA
- Analyst Count
- VRAX 0
- JVA 0
- Target Price
- VRAX N/A
- JVA N/A
- AVG Volume (30 Days)
- VRAX 13.0M
- JVA 32.0K
- Earning Date
- VRAX 11-06-2024
- JVA 09-27-2024
- Dividend Yield
- VRAX N/A
- JVA N/A
- EPS Growth
- VRAX N/A
- JVA N/A
- EPS
- VRAX N/A
- JVA 0.20
- Revenue
- VRAX $156,419.00
- JVA $76,111,698.00
- Revenue This Year
- VRAX $5,169.18
- JVA N/A
- Revenue Next Year
- VRAX $66.97
- JVA N/A
- P/E Ratio
- VRAX N/A
- JVA $11.02
- Revenue Growth
- VRAX 1727.11
- JVA 17.27
- 52 Week Low
- VRAX $0.60
- JVA $0.67
- 52 Week High
- VRAX $9.00
- JVA $3.25
- Technical
- Relative Strength Index (RSI)
- VRAX 46.62
- JVA 61.51
- Support Level
- VRAX $2.40
- JVA $1.98
- Resistance Level
- VRAX $3.26
- JVA $2.14
- Average True Range (ATR)
- VRAX 0.75
- JVA 0.15
- MACD
- VRAX -0.31
- JVA 0.01
- Stochastic Oscillator
- VRAX 9.18
- JVA 92.50
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in the business of wholesale coffee operations, including manufacturing, roasting, packaging, marketing and distributing roasted and blended coffees for private labeled accounts and its own brands, and it sells green coffee. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada and certain countries in Asia.